Analysis of the HIV/AIDs disease burden in Mexico (1995-2021): progress in mortality and challenges in prevention.

Authors

Enrique Bravo-García, Linda Morales-Juárez, Adriana Villafuerte-García, Carlos Magis-Rodríguez, Christian Razo, Rafael Lozano

Published in

Gaceta medica de Mexico. Volume 161. Issue 5. Pages 501-510.

Abstract

Human immunodeficiency virus (HIV) infection and aquired immune deficiency syndrome (AIDS) is a public health problem in Mexico. The publication of the estimates from the Global Burden of Disease (GBD) study 2021 represents a valuable opportunity to assess the evolution of the epidemic in the country.
To analyze the evolution of HIV/AIDS incidence and mortality in Mexico from 1995 to 2021.
The HIV/AIDS burden was evaluated using incidence and mortality indicators, utilizing the estimates from the GBD 2021 from 1995 to 2021.
The age-standardized HIV incidence rate in Mexico increased by 64%, rising from 7.7 to 12.6 new cases per 100,000 inhabitants. In contrast, the age-standardized mortality rate decreased by 30%, from 5.7 to 4.0 deaths per 100,000 inhabitants. Significant differences in incidence and mortality trends were observed across federal entities, age groups, and sexes.
Despite the notable reduction in HIV/AIDS mortality, incidence has shown a sustained increase since 1995, especially among older adults and young people. These trends raise questions regarding the effectiveness of the preventive strategies implemented in Mexico over the past three decades.

PMID:
42476564
Bibliographic data and abstract were imported from PubMed on 21 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.